Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000899866-20-000012
Filing Date
2020-02-04
Accepted
2020-02-04 06:30:53
Documents
162
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alxn10k12312019.htm   iXBRL 10-K 4682556
2 EXHIBIT 4.2 descriptionofsecurities.htm EX-4.2 7584
3 EXHIBIT 10.38 nqdcplandocamendmentan.htm EX-10.38 128649
4 SUBSIDIARIES OF ALEXION PHARMACEUTICALS, INC. alxnex21112312019.htm EX-21.1 14361
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP alxnex23112312019.htm EX-23.1 2948
6 CERTIFICATION OF CEO PURSUANT TO SECTION 302 alxnex31112312019.htm EX-31.1 13856
7 CERTIFICATION OF CEO PURSUANT TO SECTION 302 alxnex31212312019.htm EX-31.2 14027
8 CERTIFICATION OF CEO PURSUANT TO SECTION 906 alxnex32112312019.htm EX-32.1 7214
9 CERTIFICATION OF CEO PURSUANT TO SECTION 906 alxnex32212312019.htm EX-32.2 7122
15 a5yearcumulativereturnchart.jpg GRAPHIC 41895
16 alawresizea02.jpg GRAPHIC 41252
17 alexionlogoa55.jpg GRAPHIC 15115
18 briangoffatriuma01.jpg GRAPHIC 43993
19 chart-6dc6720976a05c15811.jpg GRAPHIC 19967
20 chart-7dc676e89ddb7ca803b.jpg GRAPHIC 11023
21 chart-10d942a968fb5eeda63.jpg GRAPHIC 18473
22 chart-61aaea1386685585b42.jpg GRAPHIC 31962
23 chart-290edd42576759848a9.jpg GRAPHIC 31283
24 chart-389e50c21c4c55148cf.jpg GRAPHIC 37229
25 chart-779e96e2965b5064972.jpg GRAPHIC 24231
26 chart-3588eeef93465231922.jpg GRAPHIC 25051
27 chart-4831ba4c20ee5c948ac.jpg GRAPHIC 19028
28 chart-8629b14773865e62ba9.jpg GRAPHIC 19651
29 chart-97148ccb37735d43b7b.jpg GRAPHIC 24439
30 chart-af3cda8f1cd35c8ea80.jpg GRAPHIC 9687
31 chart-b2f8bd888abf5624a3c.jpg GRAPHIC 11447
32 chart-c2dd8d6016ac5676bc3.jpg GRAPHIC 7674
33 chart-cd38beea22725ee6948.jpg GRAPHIC 11915
34 chart-eed55efe78fd56bab48.jpg GRAPHIC 23822
35 chart-ef96bc56b73859518e6.jpg GRAPHIC 24871
36 chart-f0b5453bf67e5cc4861.jpg GRAPHIC 44620
37 chart-f58bd2ea7a695335998.jpg GRAPHIC 12570
38 echiniaraa01.jpg GRAPHIC 41669
39 kanumaimagea08.jpg GRAPHIC 15518
40 leadershiparadhanasarin.jpg GRAPHIC 31029
41 leadershipindranifranchini.jpg GRAPHIC 44551
42 leadershipjohnorloff2a04.jpg GRAPHIC 40897
43 ludwighanstona04.jpg GRAPHIC 31211
44 solirisimagea08.jpg GRAPHIC 13121
45 strensiqimagea08.jpg GRAPHIC 12410
46 tanishacorinaedit.jpg GRAPHIC 311096
47 ultomirisr2.jpg GRAPHIC 20633
  Complete submission text file 0000899866-20-000012.txt   23743315

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxn-20191231.xsd EX-101.SCH 112967
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alxn-20191231_cal.xml EX-101.CAL 171058
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alxn-20191231_def.xml EX-101.DEF 616490
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxn-20191231_lab.xml EX-101.LAB 1519178
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxn-20191231_pre.xml EX-101.PRE 949952
88 EXTRACTED XBRL INSTANCE DOCUMENT alxn10k12312019_htm.xml XML 4403005
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

EIN.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27756 | Film No.: 20570599
SIC: 2834 Pharmaceutical Preparations